Edmonton patients requiring complete single-tablet HIV therapy can access Spegra at considerably reduced cost compared to brand Odefsey, with identical Dolutegravir/Emtricitabine/TAF combination and WHO-GMP quality assurance.
|
FAQ: What's the difference between Spegra and older two-drug HIV combinations? Spegra's three-drug combination — including the integrase inhibitor Dolutegravir — generally provides faster viral suppression and a higher barrier to resistance development compared to older two-drug combinations that relied solely on NRTIs. Dolutegravir-based regimens are now recommended as preferred first-line therapy in most international guidelines specifically because of this improved resistance profile and rapid efficacy. |